Venus Remedies has received approval of marketing authorizations (MAs) for Enoxaparin 40 mg/0.4 ml and 60 mg/0.6 ml in Azerbaijan, marking the first entry of these products into the country. Enoxaparin Sodium Injection, a low molecular weight heparin, effectively prevents blood clot enlargement and formation, addressing various medical conditions.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.